ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,838, issued on Sept. 23, was assigned to Consejo Superior de Investigaciones Cientificas (CSIC) (Madrid) and BIOINICIA S.L. (Valencia, Spain).

"Pharmaceutical formulation with improved solubility and bioavailability" was invented by Jose Maria Lagaron Cabello (Valencia, Spain), Cristina Prieto Lopez (Lugo, Spain), Jose Manuel Valle Baz (Castellon de la Plana, Spain), David Galan Nevado (Malaga, Spain) and Julia Hrakovsky (Gdynia, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical formulation comprising at least one active pharmaceutical ingredient (API) having low aqueous solubility or a pharmace...